Free Trial

Anika Therapeutics (ANIK) Earnings Date, Estimates & Call Transcripts

Anika Therapeutics logo
$9.33 +0.20 (+2.19%)
Closing price 04:00 PM Eastern
Extended Trading
$9.13 -0.20 (-2.19%)
As of 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Anika Therapeutics Earnings Summary

Anika Therapeutics posted Q4 2024 earnings on March 12, 2025, reporting an EPS of -$0.14, which missed the consensus estimate of -$0.01 by $0.13. Quarterly revenue was reported to be $30.60 million, above the consensus estimate of $29 million. With a trailing EPS of -$4.15, Anika Therapeutics' earnings are expected to grow next year, from ($0.84) to ($0.41) per share.

Upcoming
Earnings Date
Oct. 30After Market ClosesEstimated
Consensus EPS
(Mar. 12)
-$0.01
Actual EPS
(Mar. 12)
-$0.14 Missed By -$0.13
Actual Revenue
(Mar. 12)
$30.60M

Q4 2024 Earnings Resources

ANIK Upcoming Earnings

Anika Therapeutics' next earnings date is estimated for Thursday, October 30, 2025, based on past reporting schedules.

Get Anika Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anika Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ANIK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANIK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anika Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251$0.22$0.22$0.22
Q2 20251$0.26$0.26$0.26
Q3 20251$0.39$0.39$0.39
Q4 20251$0.44$0.44$0.44
FY 2025 4 $1.31 $1.31 $1.31
Q1 20261-$0.16-$0.16-$0.16
Q2 20261-$0.14-$0.14-$0.14
Q3 20261-$0.09-$0.09-$0.09
Q4 20261-$0.09-$0.09-$0.09

Anika Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/30/2025
(Estimated)
--------
3/12/2025Q4 2024-$0.01-$0.14 -$0.13-$1.50$29.00M$30.60M
8/8/2024Q2 2024$0.23-$0.01 -$0.24$0.01$39.90M$41.92M
5/8/2024Q1 2024$0.13$0.09 -$0.04$0.49$39.23M$40.52M
3/13/2024Q4 2023-$0.15$0.05+$0.20$4.40$41.51M$42.97M

Anika Therapeutics Earnings - Frequently Asked Questions

Anika Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based off last year's report dates. Learn more on ANIK's earnings history.

In the previous quarter, Anika Therapeutics (NASDAQ:ANIK) missed the analysts' consensus estimate of ($0.01) by $0.13 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. ANIK's actual earnings.

The conference call for Anika Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Anika Therapeutics' latest earnings report can be read online.
Read Transcript

Anika Therapeutics (NASDAQ:ANIK) has a recorded annual revenue of $119.91 million.

Anika Therapeutics (NASDAQ:ANIK) has a recorded net income of -$56.38 million. ANIK has generated -$4.15 earnings per share over the last four quarters.

Anika Therapeutics' earnings are expected to grow from ($0.84) per share to ($0.41) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ANIK) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners